Haemophilia: Difference between revisions

No edit summary
No edit summary
 
(37 intermediate revisions by 10 users not shown)
Line 1: Line 1:
   
   
<div class="editorbox">
<div class="editorbox">
'''Original Editors '''- [[Pathophysiology of Complex Patient Problems|Alyssa Elliott, Chelsea Reinhart]]  
'''Original Editors '''- [[Pathophysiology of Complex Patient Problems|Alyssa Elliott, Chelsea Reinhart]], [https://members.physio-pedia.com/instructor/alaa-kora/ Alaa Kora]


'''Top Contributors''' - {{Special:Contributors/{{FULLPAGENAME}}}} &nbsp;  
'''Top Contributors''' - {{Special:Contributors/{{FULLPAGENAME}}}} &nbsp;  
</div>  
</div>  
== Definition/Description ==
== Introduction ==
Haemophilia is a term that describes a rare (usually inherited) bleeding disorder that leads to haemorrhage in various body parts. It has various types and each type is different according to the factor that is deficient.<ref>Escobar M, Nguyen T. Hemophilia. In: [https://www.sciencedirect.com/science/article/pii/B9780128012383000659?via%3Dihub Reference Module in Biomedical Research] [Internet]. 3rd ed. Elsevier Inc.; 2014. p. 1–8. </ref> It is also known as the royal disease.<ref name=":0">O’Neill C. [https://hekint.org/2020/02/10/royal-blood-queen-victoria-and-the-legacy-of-hemophilia-in-european-royalty/ Royal blood: Queen Victoria and the legacy of hemophilia in European royalty] [Internet]. Hekton International. 2020 [cited 2020 Jul 1].</ref>


Hemophilia is a congenital X-linked bleeding disorder in which blood does not properly clot. It is categorized as a disorder of hemostasis. Hemostasis, the stopping of bleeding after a blood vessel is injured, normally is divided into two separate processes—primary and secondary hemostasis. In hemophilia, secondary hemostasis (which essentially results in the formation of a fibrin clot) is defected. Thus, deficient clotting is due to an abnormality of the functional plasma-clotting proteins, factors VIII and IX, that are involved in this process. <ref name="DD">Goodman CC, Snyder TEK. Differential Diagnosis for Physical Therapists: Screening for Referral. 5th ed. St. Louis: Elsevier Inc, 2013.</ref><br>  
== Definition ==
Haemophilia is the most commonly known haemorrhagic disorder causing bleeding due to defects in the coagulation factors. This leads to delay in the coagulation process post injury. Haemophilia is usually an X linked recessive inherited disease, but in some rare conditions, it has been found to be acquired.<ref>Nesterova AP, Klimov EA, Zharkova M, Sozin S, Sobolev V, Ivanikova N V., et al. [https://doi.org/10.1016/B978-0-12-817086-1.00003-8 Diseases of the Blood. In: Disease Pathways] [Internet]. Elsevier Inc; 2019. p. 112–9. </ref><ref>Marchesini E, Morfini M, Valentino L. [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214539/ Recent advances in the treatment of hemophilia: a review]. Biologics: Targets & Therapy. 2021;15:221.</ref>{{#ev:youtube| BoXBuJSURTI}}


There are two primary types of this disease—hemophilia A and hemophilia B. Hemophilia A (or classic hemophilia) affects approximately 80% of all cases. Hemophilia B (or Christmas disease) constitutes for approximately 15% of all cases. The difference between the two types is which clotting factor is deficient. <ref name="Pathology">Peterson C, Goodman CC, The Hematologic System. In: Goodman CC, Fuller KS editors. Pathology: Implications for the Physical Therapist. 3rd ed. St. Louis: Elsevier Inc, 2009. P678-741.</ref><br>  
== History of Haemophilia ==
The observation of bleeding disorders in males happened early in the 2nd century. The Talmud stated that if 2 brothers had bled to death after circumcision then the next brother shouldn’t be circumcised. Also in the 12th century the Arabic physician al-Zahrāwī, known as Albucasis, described the death of male family members due to excessive haemorrhage after an injury.<ref name=":1">Franchini M, Mannucci PM. [https://www.thieme-connect.de/products/ejournals/abstract/10.1055/s-0034-1381232 The History of Hemophilia. Semin Thromb Hemost] [Internet]. 2014;40(5):571–6. </ref>


Injuries and surgeries can cause bleeding episodes in individuals with hemophilia. Most also experience episodes of spontaneous bleeding. In regards to bleeding, they do not bleed any faster than the average person, but they do bleed for a longer period of time.  
The first medical description of haemophilia was made by the physician John Conrad Otto in the 19th century. He successfully linked this bleeding disorder to a sex linked inheritance; this was followed by another genetic description of haemophilia by Nasse in 1820. He stated that haemophilia is transmitted from carrier mothers to their male offspring. Finally, the term “haemophilia” appeared in 1928 in the University of Zurich by Hopff.<ref name=":1" />


<br>Severity of the disease is determined by blood tests. These tests determine the percentage of clotting factor present in blood plasma; concentrations from 50%-150% is normal. The severity of hemophilia can be described as mild, moderate, and severe.  
== Genetic Inheritance ==
[[File:Genetic.png|thumb]]
The term sex-linked refers to genes on the Sex chromosomes (usually the larger chromosome “X”)<ref>Easter C. [https://www.genome.gov/genetics-glossary/Sex-Linked ​Sex Linked] [Internet]. National Human Genome Institude. 2020 [cited 2020 Jul 3]. </ref>.


<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -Mild hemophilia:[[Image:Drop of blood.jpg|right]]<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -25% of cases<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -Spontaneous hemorrhages are rare<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -Deep muscle and joint bleeding are uncommon<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -Injury, trauma, surgery, and dental injury trigger bleeding <br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -these symptoms are addressed the same as with individuals with &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;severe hemophilia<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -Moderate hemophilia:<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -15% of cases<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -Spontaneous hemorrhages are usually not an issue<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -Minor trauma can result in major bleeding incidences<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -Severe hemophilia:<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -60% of cases<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -Spontaneous bleeding<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -Slight trauma may precipitate bleeding into deep muscle and joints<ref name="Pathology" /><br>
Genetic inheritance can either be dominant or recessive.


The Diagnostic section on this page includes a table displaying severity and the levels of factor VIII or IX for each in the blood.<br>  
Females (XX) carry two X chromosomes. If a female carries a normal X-chromosome and a mutated X-chromosome. If the gene is recessive the female will be a carrier and will not suffer from the condition.<ref>Medline Plus. [https://medlineplus.gov/ency/article/002051.htm <nowiki>Sex-linked recessive [Internet].</nowiki>] National Libraray of Medicine. 2020 [cited 2020 Jul 3]. </ref> There is a 50% chance she will pass on the mutated x chromosome to her children.


<br><br><br>
Males (XY) only carry one X chromosome. If a male inherits a mutated X-chromosome he will be affected by the condition whether it is dominant or recessive.
{{#ev:youtube| Vdam8pKhRNo}}


== Prevalence ==
== Prevalence of Haemophilia ==
It was estimated that haemophilia was found in 1 in each 5000 male worldwide<ref>National Center on Birth Defects and Developmental Disabilities. [https://www.cdc.gov/ncbddd/hemophilia/facts.html What is Hemophilia?]. Centers for Disease Control and Prevention. 2020 [cited 2020 Jul 2]. </ref>. In 2019 a meta-analysis found that the number is larger than previously estimated. The researchers found that there is around 1,125,000 males that have bleeding disorders. The study also revealed that in every 100 000 males there are 17.1 with haemophilia A and 3.8 with haemophilia B <ref>Inserro A. [https://www.ajmc.com/focus-of-the-week/prevalence-of-hemophilia-worldwide-is-triple-that-of-previous-estimates-new-study-says- Prevalence of Hemophilia Worldwide Is Triple That of Previous Estimates, New Study Says] American Journal of Managed Care. 2019 [cited 2020 Jul 2]. </ref><ref>Iorio A, Stonebraker JS, Chambost H, Makris M, Coffin D, Herr C, et al. [https://www.acpjournals.org/doi/abs/10.7326/M19-1208 Establishing the Prevalence and Prevalence at Birth of Hemophilia in Males.] Ann Intern Med [Internet]. 2019 Sep 10;171(8):540–6.</ref>An updated statistic from a 2021 review found a prevalence of 12.8 per 100,000 males for haemophilia A<ref>Berntorp E, Fischer K, Hart DP, Mancuso ME, Stephensen D, Shapiro AD, Blanchette V. Haemophilia. Nature Reviews Disease Primers. 2021 Jun 24;7(1):1-9.</ref>.


Hemophilia, the most common inherited blood clotting disorder associated with clotting factor deficiencies, affects 1 in 5,000 male births. It is estimated that approximately 20,000 males in the United States, and approximately 400,000 people in the world have hemophilia. All racial and ethnic groups are affected by this disease. <ref name="Pathology" /><ref name="Guidelines Article">Srivastava A, Brewer AK, Mauser‐Bunschoten EP, Key NS, Kitchen S, Llinas A, Ludlam CA, Mahlangu JN, Mulder K, Poon MC, Street A. Guidelines for the management of hemophilia. Haemophilia. 2013 Jan 1;19(1):e1-47. http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2516.2012.02909.x/full (accessed 03 April 2016).</ref><ref name="Hemophilia Facts">Centers for Disease Control and Prevention. Hemophilia Facts. http://www.cdc.gov/ncbddd/hemophilia/facts.html (accessed 8 April 2016).</ref>
== Types of Haemophilia ==
Haemophilia is usually an inherited disease, but in rare cases, it can be acquired.


== Characteristics/Clinical Presentation  ==
=== Inherited haemophilia ===
The type of haemophilia is determined according to the protein factor that defected<ref>Hemophilia of Georgia. [https://www.hog.org/handbook/article/1/3/types-of-hemophilia <nowiki>Types of Hemophilia. In: The Hemophilia, von Willebrand Disease & Platelet Disorders Handbook [Internet]</nowiki>]. Hemophilia of Georgia; 2020 [cited 2020 Jul 3]</ref>. There are three known types of haemophilia:<ref name=":2">Shapiro AD. [https://rarediseases.org/rare-diseases/hemophilia-b/ Hemophilia B] [Internet]. National Organization of Rare Diseases. 2020. </ref><ref>Bolton-Maggs P. [https://emedicine.medscape.com/article/955690-overview Hemophilia C] [Internet]. Medscape. 2019 [cited 2020 Jul 3].</ref>


Hemophilia A and hemophilia B both present in similar ways. Bleeding occurrences can first be noted in infants when being circumcised or when receiving heel sticks, immunizations, or blood draws. Other features to be noted include the formation of hematomas (or bruising). Hematomas can present in infants or children from receiving injections or while being held (such as from being lifted by the elbows or from under the armpits). Hematomas can result from excessive bruising due to minor trauma, delayed hemorrhage after minor injury, persistent bleeding after losing a tooth, or bleeding into joints and muscles.<ref name="Pathology" />&nbsp;<br>
==== Comparison between types of haemophilia ====
{|
!
!haemophilia A
!haemophilia B
!haemophilia C
|-
|Known as
|Classical / Standard haemophilia
|Christmas haemophilia
|Rosenthal’s disease
|-
|Protein factor affected
|Factor VIII
|Factor IX
|Factor XI
|-
|Genetic Inheritance
|X linked recessive
|X linked recessive
|Autosomal recessive
|-
|Gender Affected
|Mostly males
|Mostly Males
|Females & males equally
|-
|Severity
|Mild, Moderate and Severe
|Mild, Moderate and Severe
|Mild
|}


Clinical signs and symptoms of hemophilia can present in several different ways. The most common presentation of hemophilia is hemarthrosis, in which bleeding occurs inside joint spaces. The occurrence of joint bleeds increases as a baby begins to walk; these episodes can vary in severity, from swelling with mild pain to extremely swollen with severe pain. The joint most commonly affected is the knee “followed by the ankle, elbow, hip, shoulder, and wrist<ref name="Pathology" />.<ref name="DD" /> <br>  
=== Acquired haemophilia ===
Acquired haemophilia is rare and occurs as the result of an [[Autoimmune Disorders|autoimmune disease]] that attacks the protein clotting factors (especially factor VIII) and subsequently leads to manifestations similar to haemophilia A.<ref name=":2" />


Acute hemarthrosis symptoms include: [[Image:Bruised arms.jpg|right|250x200px]]<br>&nbsp;&nbsp;&nbsp;&nbsp; • swelling<br>&nbsp;&nbsp;&nbsp;&nbsp; • pain<br>&nbsp;&nbsp;&nbsp;&nbsp; • heat around joint<br>&nbsp;&nbsp;&nbsp;&nbsp; • tenderness<br>&nbsp;&nbsp;&nbsp;&nbsp; • decreased motion<br>&nbsp;&nbsp;&nbsp;&nbsp; • tingling, aura, or prickling sensation<br>&nbsp;&nbsp;&nbsp;&nbsp; • stiffening into the position that is comfortable (usually flexion)<ref name="DD" /><br>These signs and symptoms are very important for individuals with hemophilia to be aware of. When they present, steps should be taken to address the episode of acute bleeding.  
== The Royal Disease ==
Queen Victoria was a carrier of haemophilia B. She passed the mutated gene to three of her children. Her two daughters became carriers and her son, Prince Leopold, had haemophilia. Queen Victoria’s children married many royals across Europe and Russia. Haemophilia B was spread among royals for many generations with royals being either a carrier or haemophilic.<ref name=":0" /><ref>Mathew G. [https://www.medlife.com/blog/hemophilia-the-royal-disease/ <nowiki>Know All About Hemophilia – The Royal Disease [Internet]</nowiki>]. Medlife Wellness. 2020 [cited 2020 Jul 3]. Available from: </ref>


If there are recurrent episodes of hemarthrosis, hemophiliac joint disease may develop. This disease can lead to further symptoms such as:<br>&nbsp;&nbsp;&nbsp;&nbsp; • progressive decreased motion<br>&nbsp;&nbsp;&nbsp;&nbsp; • flexion contractures<br>&nbsp;&nbsp;&nbsp;&nbsp; • muscle atrophy<ref name="DD" />
== Manifestations of Haemophilia ==
Children with mild haemophilia do not show any manifestation except post-injury or dental extraction. Moderate and severe haemophiliacs may experience the following manifestations:<ref>[https://hemophilianewstoday.com/symptoms-of-hemophilia/ Symptoms of Hemophilia [Internet]]. Hemophilia News Today. 2020 [cited 2020 Jul 5]. </ref>
* Mouth bleeding post-dental extraction or cut.
* Nose bleedings
* Un-stoppable haemorrhage after a small injury or cut
* [[Blood Physiology|Blood]] in urine and stool due to haemorrhage in the kidney / bladder/ intestines or stomach
* Haematoma
* Joint Bleeding
* Muscle Bleeding


The second most common presentation of hemophilia is muscle hemorrhage, where bleeding occurs into muscles. A muscle hemorrhage can be massive and more insidious. They commonly occur in muscles that flex such as the gastrocnemius, iliopsoas, and the forearm flexor surface. The symptoms presenting with muscle hemorrhage can include: <br>&nbsp;&nbsp;&nbsp;&nbsp; • gradually intensifying pain <br>&nbsp;&nbsp;&nbsp;&nbsp; • loss of sensation<br>&nbsp;&nbsp;&nbsp;&nbsp; • decreased motion at surrounding joints<br>&nbsp;&nbsp;&nbsp;&nbsp; • muscle assuming comfortable position (usually shortened)<br>&nbsp;&nbsp;&nbsp;&nbsp; • protective muscle spasms<ref name="DD" /> <br><br>
== Diagnosis of Haemophilia ==


<u>Hemophilia and Women</u><br>Women with hemophilia often experience painful, heavy, long-lasting periods. They may also experience oozing after ovulation from their ovary. Females who are carriers of the hemophilia gene may also experience abnormal bleeding when their clotting factor is low and can lead to coagulation problems. Abnormal bleeding can occur from minor trauma, nosebleeds, bruising, dental extractions, and complications of pregnancy. These instances are often overlooked since hemophilia is less common in women.<ref name="Pathology" /><br><br>
=== Screening Tests ===


<br>  
==== Complete Blood Count ====
[[Blood Tests|Complete Blood Count]] (CBC) may appear normal in persons with haemophilia. If the patient has already experienced a massive haemorrhage, the CBC count may appear low.<ref name=":3">Centers for Disease Control and Prevention. [https://www.cdc.gov/ncbddd/hemophilia/diagnosis.html <nowiki>Diagnosis of Hemophilia [Internet]</nowiki>]. National Center on Birth Defects and Developmental Disabilities. 2019 [cited 2020 Jul 5]. Available from: </ref>


== Associated Co-morbidities  ==
==== Activated Partial Thromboplastin Time (APTT) Test ====
The APTT test measures the duration of blood clotting by measuring the clotting ability of factor VIII, IX, XI and XIII. In patients with haemophilia, the results will show a prolonged clotting time<ref name=":3" />.


• HIV (more common prior to 1986 because purification techniques were not in place)<br>• AIDs<br>• Hepatitis A<br>• Hepatitis B<br>• Hepatitis C<ref name="Pathology" /><br>• Osteoporosis<ref name="Aging with">Living With Hemophilia. Aging with hemophilia. http://www.livingwithhemophilia.ca/adults-teens/aging.php (accessed 3 April 2016).</ref>  
==== Prothrombin Time (PT) Test ====
The PT test measures the duration of blood clotting by measuring the clotting ability of factor I, II, V, VII. In patients with haemophilia, the results are normal.<ref name=":3" />


Individuals with hemophilia are also at a higher risk for developing hypertension, heart disease, kidney disease, obesity, and sexual dysfunction compared to the general population.<ref name="Aging with" /> <br><br>  
=== Clotting Factor Tests ===
Clotting factor tests are used to diagnosis haemophilia and its type and the degree of severity.  It measures the levels of factor VIII and IX.<ref name=":3" />


== Medications  ==
== The Severity of Haemophilia ==
The severity of haemophilia is determined by the levels of clotting factor in the blood.<ref name=":3" />


Individuals with hemophilia may take pain medications “to control pain in acute bleeding and chronic arthropathies” (joint diseases)<ref name="Pathology" />. Common pain medications, including acetylsalicylic acid (ASA) and nonsteroidal anti-inflammatory drugs (NSAIDs), for instance ibuprofen and aspirin, cannot be used due to their platelet inhibiting function. In addition, any medication with derivatives of aspirin must be used cautiously (i.e. corticosteroids which may be used for chronic synovitis). Certain COX-2 inhibitors as well as acetaminophen are safe pain medication alternatives.<ref name="Guidelines Article" /><br>
==== Severity of haemophilia ====
 
{|
== Diagnostic Tests/Lab Tests/Lab Values  ==
!Severity
 
!Levels of Factor VIII or IX in the blood
[[Image:Microscope.jpg|right]]In order to diagnose hemophilia, screening tests will be performed, as well as clotting factor tests (also called factor assays). The blood tests reveal the type and severity of hemophilia. If there is a family history of hemophilia, a mother can also request to have a blood test performed from the baby boy’s umbilical cord immediately after birth.<ref name="Hemophilia Diagnosis">Centers for Disease Control and Prevention. Hemophilia Diagnosis. http://www.cdc.gov/ncbddd/hemophilia/diagnosis.html (accessed 3 April 2016).</ref>
|-
 
|Normal
'''Screening Tests:'''
|50% to 100%
 
|-
Complete Blood Count (CBC)
|Mild haemophilia
 
|Greater than 5% but less than 50%
*This test measures the number and size of red blood cells, the amount of hemoglobin, and the platelet number in the blood. This value is normal for people with hemophilia, but the red blood cell and hemoglobin counts can be low with bleeding for an extended period of time or when individuals have unusually heavy episodes of bleeding.<ref name="Hemophilia Diagnosis" />
|-
|Moderate haemophilia
|1% to 5%
|-
|Severe haemophilia
|Less than 1%
|}


Activated Partial Thromboplastin Time (APTT) Test<br>
== Medical Management ==


*This test measures the time it takes for blood to clot while measuring the “clotting ability of factors VIII (8), IX (9), XI (11), and XII (12)<ref name="Hemophilia Diagnosis" />.” A person with hemophilia would display an increased blood clotting time in their results.
=== Replacement Therapy ===
Concentrates of clotting factor VIII (for haemophilia A) or clotting factor IX (for haemophilia B) are slowly injected into a vein to replace the missed clotting factor. These concentrates can be extracted from human blood or synthesized (recombinant clotting factor).<ref name=":4">National Heart, Lung, and Blood Institute NI of H. [https://www.hoacny.com/patient-resources/blood-disorders/what-hemophilia/how-hemophilia-treated How Is Hemophilia Treated?] [Internet]. Centers for Cancer Care and Blood Disorders. 2020 [cited 2020 Jul 5]. </ref>


Prothrombin Time (PT) Test
==== Preventative (prophylactic) therapy ====
Preventative therapy encompasses the usage of replacement therapy on a regular basis to prevent bleeding.<ref name=":4" />


*This test measures how long it takes for the blood to clot while primarily measuring the “clotting ability of factors I (1), II (2), V (5), VII (7), and X (10)<ref name="Hemophilia Diagnosis" />.” Results will typically be normal for individuals with hemophilia.
Demand therapy


Fibrinogen Test
Demand therapy is a less intensive approach that encompasses the usage of replacement therapy only when the need arises.<ref name=":4" />


*This test allows physicians to assess their patient’s ability to form blood clots. This test is usually performed if a patient has abnormal APTT and/or PT test results, and may also be performed along with other clotting tests.<ref name="Hemophilia Diagnosis" />
==== Complications of Replacement Therapy<ref name=":4" /> ====
* May develop antibodies that attack the clotting factor
* Susceptible to viral infections from human clotting factors
* Damage to joints, muscles, or other parts of the body resulting from bleeding as a result of delays in treatment


'''Clotting Factor Tests:'''<br>• These are required for a bleeding disorder to be diagnosed. This blood test reveals the type and severity of hemophilia.<ref name="Hemophilia Diagnosis" />[[Image:Vile.jpg|left]]<br><br>
=== Other Types of Treatment ===
Other types include Desmopressin (stimulates the production of the clotting factors), Antifibrinolytic Medicines and gene therapy)<ref name=":4" />.


{| width="549" cellspacing="1" cellpadding="1" border="1" align="center"
==== Recommended Treatment according to the severity of haemophilia ====
{|
!Severity of haemophilia
!Recommended Medical Management
|-
|-
! scope="col" | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Severity of Hemophilia&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>
|Mild haemophilia
! scope="col" | Factor VIII or IX Levels in the Blood<br>
|Desmopressin
|-
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp; Mild<br>
|  
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp; &gt;5% but &lt;50%<br>


No replacement therapy
|-
|-
|  
|Moderate haemophilia
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Moderate<br>
|Desmopressin


| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp; 1% - 5%<br>
Replacement therapy during bleeding / prevent bleeding prior certain activities  or surgeries
|-
|-
|  
|Severe haemophilia
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp; &nbsp; Severe<br>
|Replacement therapy
 
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &lt;1%<br>
|}
|}


Modified From: Centers for Disease Control and Prevention [Internet]. Diagnosis; 13 September 2011 [cited 8 April 2016]. Available from: http://www.cdc.gov/ncbddd/hemophilia/diagnosis.html <br>  
== Physical Therapy Management ==
The National haemophilia  Foundation formed a physical therapy working group that created the best physical therapy practice for bleeding disorders including haemophilia.<ref name=":5">Lowes LP, Alfano L, Orlin MN. Muscloskeltal System: [https://books.google.com/books?hl=en&lr=&id=kSFhAQAAQBAJ&oi=fnd&pg=PR4&dq=Lowes+Considerations+and+Interventions+for+Specific+Pediatric+Pathology.+In:+Effgen+SK,+editor.+Meeting+the+Physical+Therapy+Needs+of+Children.&ots=me7Zvhd4wV&sig=H0mG2hKu2pOrj8Apf5 Considerations and Interventions for Specific Pediatric Pathology. In: Effgen SK, editor. Meeting the Physical Therapy Needs of Children.] 2nd ed. Philadelphia: F. A. Davis Company; 2013. p. 226–7.</ref>


== Etiology/Causes  ==
The Medical and Scientific Advisory Council (MASAC) recommends physical therapy management in haemophilia because the most common manifestation is joint and muscle bleeding.<ref>Medical and Scientific Advisory Counsil. MASAC Document #238: [https://www.hemophilia.org/sites/default/files/document/files/238PTGuidelines.pdf Recommendations Regarding Physical Therapy Guidelines in Patients with Bleeding Disorders.] Natl Hemoph Found. 2015;238.</ref>


Blood clotting factors VIII and IX are found on the X chromosome making this an X-linked disorder, and thus making hemophilia rare in females. Since females carry two X-chromosomes, they only develop hemophilia when both chromosomes are affected. Males will always develop hemophilia when they carry an affected X-chromosome (since they only have one). Two-thirds of hemophilia cases have an evident familial history, however, one-third of cases result from spontaneous genetic mutation.<ref name="Pathology" /><ref name="Guidelines Article" /><br>  
Joints that have recurrent bleedings in haemophilia are known as “Target Joints”. The most common target joints are knee, elbow, ankle, hip and shoulders.<ref name=":5" />


[[Image:Genetics1.png|left]]
The physiotherapy management of haemophilia is very similar to the management of Von Willebrand Disease.


[[Image:Genetics2.png|center]]<br>  
Physiotherapy can also play a role in providing support and coaching, and in monitoring the musculoskeletal status of people with haemophilia.<ref>Lobet S, Timmer M, Königs C, Stephensen D, McLaughlin P, Duport G, Hermans C, Mancuso ME. [https://www.mdpi.com/2077-0383/10/13/2822/pdf The Role of Physiotherapy in the New Treatment Landscape for Haemophilia]. Journal of Clinical Medicine. 2021 Jun 26;10(13):2822.</ref>


== Systemic Involvement  ==
=== Physical Therapy Evaluation ===
According to the MASAC; the purpose of an evaluation is to detect the musculoskeletal and activities limitations caused by haemophilia.<ref name=":6">Medical and Scientific Advisory Council. Physical Therapy Evaluation Recommendations. Natl Hemoph Found. 2018;</ref>


A person with hemophilia may develop issues with their central nervous system (CNS). Two issues that can develop are:[[Image:Nurse and man.jpg|right]]<br>&nbsp;&nbsp;&nbsp;&nbsp; • Intraspinal hemorrhage (rare)<br>&nbsp;&nbsp;&nbsp;&nbsp; • Intracranial hemorrhage (sign &amp; symptoms of this include)<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; o Irritability, lethargy<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; o Feeding difficulties (children)<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; o Seizures<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; o Unequal pupils<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; o Vomiting<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; o Apnea<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; o Tense, bulging fontanelles (children)<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; o Paralysis<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; o Death <ref name="DD" />  
==== History and Interview ====
The patient and/or the caregiver is interviewed and the history is taken<ref name=":6" />:
* Personal history.
* Family history.
* Bleeding history.
* Medical and surgical history.
* [[Pain Assessment|Pain]] history.
* [[Activities of Daily Living|ADL]] concerns.
* Occupational concerns.


A person with hemophilia may develop gastrointestinal (GI) system issues. Signs and symptoms of GI involvement include:<br>&nbsp;&nbsp;&nbsp; • Fever<br>&nbsp;&nbsp;&nbsp; • Abdominal distention and pain<br>&nbsp;&nbsp;&nbsp; • Melena (bloody stool)<br>&nbsp;&nbsp;&nbsp; • Hip flexion contracture (iliopsoas muscle spasm due to retroperitoneal hemorrhage)<br>&nbsp;&nbsp;&nbsp; • Hematemesis (vomiting blood)<br>&nbsp;&nbsp;&nbsp; • Low groin/abdominal pain (secondary to bleeding into large intestine wall or iliopsoas muscle)<ref name="DD" /><br>
==== Physical Examination ====
* Palpation of joints at rest and during active range of motion to detect crepitus, synovitis, oedema or temperature.
* Girth measurement to assess oedema/ muscle atrophy.
* Atypical Joint End feel detection via the passive range of motion.
* Manual Muscle Testing to assess muscular strength.
* Muscle Flexibility test.
* Sensation and proprioception.
* Balance and fall assessment.
* Posture and alignment assessment.
* Assessment of functional activities.
* Gait analysis.
* Neuromotor assessment.
* Musculoskeletal Ultrasound.


A person with hemophilia may develop inhibitors. The development of inhibitors is a serious complication. When this occurs, the “inhibitors (also called antibodies) form in the blood to fight against the foreign factor proteins. This stops the factor concentrates from being able to fix the bleeding problem<ref name="Inhibitors">World Federation of Hemophilia. What are inhibitors?. http://www.wfh.org/en/page.aspx?pid=637#Inhibitors (accessed 3 April 2016).</ref>.”<br>&nbsp;&nbsp;&nbsp; Possible concerns:<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • increased difficulty controlling bleeding<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • Increased cost of care/treatments<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • Often experience more joint disease from bleeding <br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • Reduced quality of life<ref name="Hemophilia Facts" /><br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • Reduced participation in exercise/physical activity <br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • Should be monitored carefully during all activity<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • Should be treated with rest and ice for any adverse reactions<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • Should avoid high-risk sports<ref name="Benefits">Negrier C, Seuser A, Forsyth A, Lobet S, Llinas A, Rosas M, Heijnen L. The benefits of exercise for patients with haemophilia and recommendations for safe and effective physical activity. Haemophilia. 2013 Jul 1;19(4):487-98. http://onlinelibrary.wiley.com/doi/10.1111/hae.12118/full (accessed 08 April 2016).</ref><br><br>  
== Physical Therapy Treatment ==
The recommended physical therapy program by MASAC for muscles and joints bleeding is different in each recovery phase. There are three recovery phases: Acute, Subacute and Chronic. The management for all muscles follow specific guidelines, except for iliopsoas muscle, and all physical therapy suggested protocols are performed post factor replacement medication as follows:<ref>National Hemophilia Foundation. [https://www.hemophilia.org/Researchers-Healthcare-Providers/Medical-and-Scientific-Advisory-Council-MASAC/MASAC-Recommendations/MASAC-Recommendations-Regarding-Physical-Therapy-Guidelines-in-Patients-with-Bleeding-Disorders Physical Therapy Practice Guidelines for Persons with Bleeding Disorders: Muscle Bleed]. 2018;</ref>


== Medical Management (current best evidence)  ==
==== Physical Therapy Guidelines in Different Recovery Phases of Haemophilia ====
{|
!
!Acute Phase
!Subacute Phase
!Chronic
!Precautions
|-
| rowspan="2" |Muscles Bleeding except for iliopsoas
|Main Problem:


At this time, there is no known cure or prenatal treatment for hemophilia. The goal for current treatment is to stop and prevent bleeding. There are specialized comprehensive hemophilia treatment centers (HTC) to address all related issues of the disorder. HTCs provide patients with a team of “physicians (hematologists or blood specialists), nurses, social workers, physical therapists and other health care providers, who are specialized in the care of people with bleeding disorders<ref name="Hemophilia Treatment">Centers for Disease Control and Prevention. Hemophilia Treatment. http://www.cdc.gov/ncbddd/hemophilia/treatment.html (accessed 8 April 2016).</ref>”. HTCs have been proven to reduce the rates of disability, morbidity, and mortality<ref name="Pathology" />.
Present pain at rest and with movement
|Main Problem :


Factor replacement therapy via infusion utilizes clotting factor concentrates that aid in proper blood clotting; this is the best way to treat hemophilia. Individuals can learn how to perform infusions themselves to stop bleeding episodes (as soon as they occur) as well as prevent most bleeding episodes by performing infusions regularly.<ref name="Pathology" /><ref name="Hemophilia Treatment" />
Limitations in ADL without increasing pain from baseline
|Main Problem :


<u>Tips for Maintaining Health with Hemophilia</u>
ADL limitation but without pain
| rowspan="2" |
* Monitor for neurovascular compromise while Splinting
* Caution with use of compression on the affected muscle.
* Use of heat modalities including ultrasound  with precautions
* Ultrasound for blood absorption can be used with precautions.
|-
|Physical Therapy Program:


“The National Hemophilia Foundation (NHF), along with the Centers for Disease Control and Prevention (CDC), developed '''Do the 5! '''This education project is part of the National Prevention Program to help prevent or reduce the complications of bleeding disorders<ref name="Healthy Living">Steps For Living. Maintaining a Healthy Body. https://stepsforliving.hemophilia.org/step-out/maintaining-a-healthy-body/do-the-5 (accessed 10 April 2016).</ref>.”<br>
* Avoid compression in the presence of neuromuscular symptoms.
* No active movement or weight bearing till bleeding stoppage.
* Splinting.
* RICE: Rest, Ice, Compression & Elevation
* TENS
|Physical Therapy Program:


'''5 Tips for Healthy Living (from the National Hemophilia Foundation’s National Prevention Program)'''[[Image:Nurse.jpg|right]]<br>
* Splinting and assistive device to limit activity
* Toe touch weight bearing
* Isometric contractions
* Active range of motion
* Positioning
* AAROM without pain
* TENS
|Physical Therapy Program:


#Get an annual comprehensive checkup at a hemophilia treatment center
* Full Weight Bearing without assistive devices
#Get vaccinated--Hepatitis A and B are preventable
* Positional stretching
#Treat bleeds early and adequately
* Active Range of Motion exercises
#Exercise and maintain a healthy weight to protect your joints
* unrestricted lifting
#Get tested regularly for blood-borne infections<ref name="Hemophilia Facts" /><br><br>
* Re-evaluation.
|-
| rowspan="2" |Iliopsoas Muscle Bleeding
|Main Problem:


== Physical Therapy Management (current best evidence)  ==
pain presented at rest and with movement
|Main Problem :


'''Preferred Practice Patterns'''<br>''4B: Impaired Posture (joint deformity)<br>4D: Impaired Joint Mobility, Motor Function, Muscle Performance, and Range of Motion Associated with Connective Tissue Dysfunction<br>5A: Primary Prevention/Risk Reduction for Loss of Balance and Falling<br>5C: Impaired Motor Function and Sensory Integrity Associated with Nonprogressive Disorders of the Central Nervous System: Congenital Origin or Acquired in Infancy or Childhood (CNS involvement)<br>5F: Impaired Peripheral Nerve Integrity and Muscle Performance Associated with Peripheral Nerve Injury (nerve compression)<br>6F: Impaired Ventilation and Respiratory/Gas Exchange Associated with Respiratory Failure (coagulation defect)''<ref name="Pathology" /><br>
ADL limitation without increase pain from baseline
|Main Problem :


<u>Treatment Overview</u><br>Physical therapy (PT), through the use of muscular strengthening, neuromuscular re-education, gait training, and patient education, is effective in decreasing the number of bleeding episodes. It is used to prevent additional deformations (maintain joint positioning) as well as control pain and supplementary bleeding during acute hemorrhages. In regards to exercise, therapists can “help individuals with hemophilia identify, seek out, and enjoy physical activity, exercise, and sport participation that provide benefits that outweigh the risks<ref name="Pathology" />.” Fortunately, overall, medical treatment today is more aggressive in nature so less damage to joints occur. Thus, much of the focus of PT has shifted to preventative rather than rehabilitation.
ADL limitation but without pain
| rowspan="2" |Monitor for femoral nerve palsy
|-
|Physical Therapy Program :


<u>Importance of Exercise</u><br>Exercise and physical activity is imperative for this population because joint immobilization (not moving your joints) can progress to muscle diminishing, joint instability and recurrent bleeding, and the early development of arthropathy. Aquatic therapy is a great modality for individuals with hemophilia and is especially beneficial for those with chronic arthropathy due to the decreased compressive forces across joints the water vs. land provides.<ref name="Pathology" />
* Bedrest
* Toe Touch Weight Bearing for household mobility
* Rest
* Opposite limb ROM Ankle pumps involved lower limb with pain avoidance
|Physical Therapy Program:


<u>Strength Training</u><br>Strength training in individuals with hemophilia increases muscular strength, improves circulation and joint stability, and may reduce the risk of spontaneous bleeding. [[Image:Range.jpg|right|300x200px]]
* Toes touch weight bearing without increase in pain
* Isometric contractions
* Active Range Of Motion exercises to involved Lower limb without increase in pain
* Positioning with increasing hip extension Range Of Motion in supine and prone over pillows without increase in pain.
* therapeutic exercises for non-involved limb
|Physical Therapy Program:


What the physical therapist should know:<br>• Warming-up before the intervention and a cooling-down afterward are very important<br>• Perform all strength training exercises within pain-free ROM<br>• Patients should ''never'' attempt maximal lifts<ref name="Pathology" />
* Full Weight Bearing without  assistive devices
* Positional stretches from prone position
* Active range of motion exercises
* Re-evaluation
|-
| rowspan="2" |Joint Bleeding
|Main Problem:


<u>Therapy and Hemarthrosis</u><br>Therapists should be aware and alert for early signs of bleeding episodes. Early bleeding signs are listed under ''acute hemarthrosis clinical signs and symptoms'' mentioned in the Characteristics/Clinical Presentation section above.<br>During the acute episode of hemarthrosis, range of motion (ROM) should be measured within the pain-free range and ''strength tests should not be taken''.
pain presented at rest and with movement
|Main Problem :


Wraps, slings, splints, or assistive devices may be indicated. Since synovitis or articular contracture is an underlying condition of hemophilia, muscle shortening may occur. Dynamic or static night splints are useful in this case to provide a low-load stretch.<ref name="Pathology" /><br>
ADL limitation without increase pain from baseline
|Main Problem :


{| width="750" cellspacing="1" cellpadding="1" border="1" align="left"
ADL limitation but without pain
| rowspan="2" |
* Avoid aggressive exercise too early
* Monitor for nerve compression
* Use of heat modalities including ultrasound with precautions
* No return to sports or activity until pain-free full ROM and strength
|-
|-
! colspan="3" scope="col" | Joint and Muscle Bleed Management<br>
|Physical Therapy Program :
|-
| '''&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Joint: Acute Stage'''<br>
| '''&nbsp; &nbsp; &nbsp; &nbsp;&nbsp;&nbsp;&nbsp; Joint: Subacute Stage'''&nbsp;&nbsp;&nbsp; <br>
| '''&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Muscle''' <br>
|-
| Factor replacement<br>
|
Factor replacement (if indicated)&nbsp;&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;&nbsp; <br>


| Factor replacement&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>
* RICE (ice for 10-20 minutes every 1-2 hours)
|-
* Splinting
| Red, Ice, Compression (at least 10-15 minutes to area), Elevation (RICE)<br>
* Non Weight Bearing using  assistive device
| Progressive AROM exercises&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>
|Physical Therapy Program :
| RICE<br>
|-
| Pain-free ROM<br>
| Wean slings and splints<br>
| Appropriate WB status (bed rest indicated for iliopsoas bleed)<br>
|-
| Pain medication<br>
| Progressive weight bearing<br>
| Progressive movement<br>
|}


<br>
* Continue RICE for pain and after exertion Splinting
* Night resting splint for protection
* Begin progressive weight bearing
* Activity modification to avoid pain
* Pain-free gentle active Range of motion
* Pain-free progressive strengthening
|Physical Therapy Program :


<br>
* Dynamic splinting to increase ROM
 
* Active range of motion Progressive
<br>
* Strengthening as Open chain, closed chain and resistive band
 
* Proprioceptive training
<br>  
* Gentle joint mobilizations
 
* Modified functional activities
<br>  
* Orthotics
* Reevaluations
|}
There are also some modalities and physical therapy tools that have been researched across the years to help patients with haemophilia. EMG biofeedback may be helpful with muscle strenthening and relaxation <ref>Culbert T, Banez G. Pediatric Applications. In: Schwartz M, Andrasik F, editors. Biofeedback, Fourth Edition: A Practitioner’s Guide. 4th ed. The Guilford Press; 2017.</ref>


<br>  
== Kinesio Tape ==
It was shown the [[Kinesiology Taping|Kinesio tape]] plays a role in haemophilia by supporting the [[Muscle|muscles]], allowing joint movement with support, decreasing pain and decreasing hematoma.<ref>Zolotnitsky M. [https://www.biomatrixsprx.com/bleeding-disorders-articles/the-benefits-of-kinesio-taping-ask-the-hemodoc <nowiki>The Benefits of Kinesio Taping: Ask The HemoDoc [Internet].</nowiki>] BioMatrix. 2019 [cited 2020 Jul 5]. </ref>{{#ev:youtube| VIGIgEHN-wA}}


<br>  
== Transcutaneous Electrical Neurostimulation  ==
It was shown that Transcutaneous electrical neurostimulation ([[Transcutaneous Electrical Nerve Stimulation (TENS)|TENS]]) has an impact on reducing pain for patients with haemophilia. It is applied as a low intensity electrical impulse to stimulate peripheral nerves. That inhibits pain information transmission along nerves.<ref>Riley RR, Witkop M, Hellman E, Akins S. [http://www1.wfh.org/publications/files/pdf-1216.pdf Assessment and management of pain in Hemophilia Patients]. Hemophilia. 2011;17:839–45.</ref>


<br>  
Related update: another treatment modality available to some physiotherapists, laser therapy, is showing promise for improving the functional capacity of patients with haemophilic arthropathy.<ref>Elshennawy S, Zahreldin AA, Mortada H, Hozien M, Youssef AS, Galal A, Shahien M, Elfeky A, Elaraby A, Hamed M. The efficacy of Physical therapy modalities in patients with haemophilia: a systematic review of randomized controlled trials with meta-analysis. Archives of Physical Medicine and Rehabilitation. 2022 Jul 19.</ref>


Modified from Peterson C, Goodman CC, The Hematologic System. In: Goodman CC, Fuller KS editors. Pathology: Implications for the Physical Therapist. 3rd ed. St. Louis: Elsevier Inc, 2009. P726.<br>  
== Manual Therapy ==
[[Manual Therapy|Manual therapy]] such as fascial therapy, passive mobilization and [[stretching]]; manual orthopaedic therapy and [[proprioception]] training are recommended for physical therapy management for cases with haemophilia,<ref>Donoso-Úbeda E, Meroño-Gallut J, López-Pina JA, Cuesta-Barriuso R. [https://scholar.google.com/scholar_url?url=https://journals.sagepub.com/doi/abs/10.1177/0269215519879212&hl=en&sa=T&oi=gsb&ct=res&cd=0&d=2171032745800138323&ei=D7weX-XdDI2KmwHh0b-QBA&scisig=AAGBfm2rwhYL5eEk8sbEL_oG43_ja3tg3w Effect of manual therapy in patients with hemophilia and ankle arthropathy: a randomized clinical trial]. Clin Rehabil. 2020;34(1):111–9</ref> but joint traction as a manual therapy technique.<ref>Cuesta-Barriuso R, Trelles-Martínez RO. [https://scholar.google.com/scholar_url?url=https://link.springer.com/article/10.1186/s12891-018-1934-9&hl=en&sa=T&oi=gsb-ggp&ct=res&cd=0&d=15294112181899765149&ei=OrweX8KWIIjHmAHwp7ToDA&scisig=AAGBfm04h4LVYQBwfnyfrLuCCoInrCrK4g Manual therapy in the treatment of patients with hemophilia B and inhibitor]. BMC Musculoskelet Disord. 2018;19(1):1–5.</ref>


Joint range of motion (ROM) limitations can occur post muscle shortening from repeated bleeds in the same body area. Splinting or serial casting may be indicated for these individuals. <br>Leg length discrepancy, a long-term result of joint arthropathy, must be monitored and managed to prevent further impairments (such as low back pain).<ref name="Pathology" /> <br>  
haemophilia is a congenital X-linked bleeding disorder in which blood does not properly clot. It is categorized as a disorder of haemostasis. haemostasis, the stopping of bleeding after a blood vessel is injured, normally is divided into two separate processes—primary and secondary haemostasis. In haemophilia, secondary haemostasis (which essentially results in the formation of a fibrin clot) is defected. Thus, deficient clotting is due to an abnormality of the functional plasma-clotting proteins, factors VIII and IX, that are involved in this process. <ref name="DD">Goodman CC, Snyder TEK. Differential Diagnosis for Physical Therapists: Screening for Referral. 5th ed. St. Louis: Elsevier Inc, 2013.</ref><br>  


== Differential Diagnosis  ==
== Differential Diagnosis  ==


It is important to ensure hemophilia is properly diagnosed. Below are other medical issues or impairments that may present similarly and if not diagnosed appropriately could lead to a variety of medical issues.  
It is important to ensure haemophilia is properly diagnosed. Below are other medical issues or impairments that may present similarly and if not diagnosed appropriately could lead to a variety of medical issues.  


*Nerve impingement: A person with hemophilia may experience bleeding into the iliacus muscle or the psoas. Bleeding in these areas can apply pressure to the femoral nerve branch that supplies the skin of the anterior thigh and a person may have loss of sensation.  
*Nerve impingement: A person with haemophilia may experience bleeding into the iliacus muscle or the [[Psoas Major|psoas]]. Bleeding in these areas can apply pressure to the [[Femoral Nerve|femoral nerve]] branch that supplies the skin of the anterior thigh and a person may have a loss of sensation.  
*Appendicitis: A person with hemophilia may have symptoms that mimic appendicitis when they have muscle bleeding on the right side in their lower abdomen.<ref name="DD" />  
*Appendicitis: A person with haemophilia may have symptoms that mimic appendicitis when they have muscle bleeding on the right side in their lower abdomen.<ref name="DD" />  
*Disseminated Intravascular Coagulation (DIC)<ref name="DIC">MedlinePlus. Disseminated intravascular coagulation (DIC). https://www.nlm.nih.gov/medlineplus/ency/article/000573.htm (accessed 8 April 2016).</ref><br>  
*Disseminated Intravascular Coagulation (DIC)<ref name="DIC">MedlinePlus. Disseminated intravascular coagulation (DIC). https://www.nlm.nih.gov/medlineplus/ency/article/000573.htm (accessed 8 April 2016).</ref><br>  
*Von Willebrand Disease (VWD)<ref name="VWD">Centers for Disease Control and Prevention. Facts About von Willebrand Disease. http://www.cdc.gov/ncbddd/vwd/facts.html (accessed 8 April 2016).</ref>  
*[[Von Willebrand Disease]] (VWD)<ref name="VWD">Centers for Disease Control and Prevention. Facts About von Willebrand Disease. http://www.cdc.gov/ncbddd/vwd/facts.html (accessed 8 April 2016).</ref>  
*Thrombocytopenia<ref name="Thrombo">National Heart, Lung, and Blood Institute. What Is Thrombocytopenia?. http://www.nhlbi.nih.gov/health/health-topics/topics/thcp/ (accessed 8 April 2016).</ref><br>
*Thrombocytopenia<ref name="Thrombo">National Heart, Lung, and Blood Institute. What Is Thrombocytopenia?. http://www.nhlbi.nih.gov/health/health-topics/topics/thcp/ (accessed 8 April 2016).</ref><br>


== Case Reports/ Case Studies  ==
== Case Reports/ Case Studies  ==


1. Girardi D da M, Silva DRA, Villaça PR, Souza CE, Fonseca LG, Bastos DA, Hoffa PMG. Acquired hemophilia A in a patient with advanced prostate cancer. Journal of Autopsy &amp; Case Reports. 2015;5(2):55-59.<br>  
# Girardi D da M, Silva DRA, Villaça PR, Souza CE, Fonseca LG, Bastos DA, Hoffa PMG. Acquired haemophilia A in a patient with advanced prostate cancer. Journal of Autopsy &amp; Case Reports. 2015;5(2):55-59. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4584669/
 
# Iioka F, Shimomura D, Nakamura F, Ohno H, Yada K, Nogami K, Shima M. Long-term treatment course of a patient with mild haemophilia A who developed a high titre factor VIII inhibitor. Journal of Haemophilia. 2014;20(6):e402-e404.<br>http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232888/<br>
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4584669/<br>  
# Janbain M, Leissinger CA, Kruse-Jarres R. Acquired haemophilia A: emerging treatment options. Journal of blood medicine. 2015;6:143-150.<br>http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431493/<br><br>  


<br>2. Iioka F, Shimomura D, Nakamura F, Ohno H, Yada K, Nogami K, Shima M. Long-term treatment course of a patient with mild haemophilia A who developed a high titre factor VIII inhibitor. Journal of Haemophilia. 2014;20(6):e402-e404.<br>http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232888/<br>
== Resources    ==


<br>
* [https://www.hemophilia.org/healthcare-professionals/guidelines-on-care/masac-documents/masac-document-238-recommendations-regarding-physical-therapy-guidelines-in-patients-with-bleeding-disorders National Hemophilia Foundation: Recommendations Regarding Physical Therapy]


3. Janbain M, Leissinger CA, Kruse-Jarres R. Acquired hemophilia A: emerging treatment options. Journal of blood medicine. 2015;6:143-150.<br>
* National Haemophilia Foundation: [https://www.hemophilia.org/ https://www.haemophilia.org/]
 
* Genetics Home Reference page for haemophilia: [https://ghr.nlm.nih.gov/condition/hemophilia https://ghr.nlm.nih.gov/condition/haemophilia]
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431493/<br><br>
* CDC page for haemophilia: [http://www.cdc.gov/ncbddd/hemophilia/ http://www.cdc.gov/ncbddd/haemophilia/]
 
* Information for people with haemophilia: [http://www.cdc.gov/ncbddd/hemophilia/people.html http://www.cdc.gov/ncbddd/haemophilia/people.html]
== Resources <br>  ==
* haemophilia Federation of America: [http://www.hemophiliafed.org/ http://www.haemophiliafed.org/]
 
* Merck Manual Professional Version: haemophilia: [http://www.merckmanuals.com/professional/hematology-and-oncology/coagulation-disorders/hemophilia http://www.merckmanuals.com/professional/hematology-and-oncology/coagulation-disorders/haemophilia]
• National Hemophilia Foundation: https://www.hemophilia.org/  
* Merck Manual Consumer Version: haemophilia: [http://www.merckmanuals.com/home/blood-disorders/bleeding-due-to-clotting-disorders/hemophilia http://www.merckmanuals.com/home/blood-disorders/bleeding-due-to-clotting-disorders/haemophilia]
 
* Steps for Living - haemophilia: [https://stepsforliving.hemophilia.org/basics-of-bleeding-disorders https://stepsforliving.haemophilia.org/basics-of-bleeding-disorders]<br />
Genetics Home Reference page for hemophilia: https://ghr.nlm.nih.gov/condition/hemophilia  
 
CDC page for hemophilia: http://www.cdc.gov/ncbddd/hemophilia/  
 
Information for people with Hemophilia: http://www.cdc.gov/ncbddd/hemophilia/people.html  
 
• Hemophilia Federation of America: http://www.hemophiliafed.org/  
 
Merck Manual Professional Version: Hemophilia: http://www.merckmanuals.com/professional/hematology-and-oncology/coagulation-disorders/hemophilia  
 
Merck Manual Consumer Version: Hemophilia: http://www.merckmanuals.com/home/blood-disorders/bleeding-due-to-clotting-disorders/hemophilia  
 
Steps for Living - Hemophilia: https://stepsforliving.hemophilia.org/basics-of-bleeding-disorders<br><br>
 
== Recent Related Research (from [http://www.ncbi.nlm.nih.gov/pubmed/ Pubmed])&nbsp;  ==
 
see tutorial on [[Adding PubMed Feed|Adding PubMed Feed]]
<div class="researchbox"><rss>http://www.ncbi.nlm.nih.gov/entrez/eutils/erss.cgi?rss_guid=1DgoOSh9lgMeQe0kYSNMqScPOvFMV7iAfeczBF_hGbCyU-JMHQ|charset=UTF-8|short|max=10</rss><br></div>  
== References  ==
== References  ==
see [[Adding References|adding references tutorial]].


<references />  
<references />  


[[Category:Bellarmine_Student_Project]]
[[Category:Bellarmine_Student_Project]]
[[Category:Course Pages]]
[[Category:Plus Content]]
[[Category:Blood Disorders]]
[[Category:Genetic Disorders]]

Latest revision as of 22:12, 29 March 2024

 

Introduction[edit | edit source]

Haemophilia is a term that describes a rare (usually inherited) bleeding disorder that leads to haemorrhage in various body parts. It has various types and each type is different according to the factor that is deficient.[1] It is also known as the royal disease.[2]

Definition[edit | edit source]

Haemophilia is the most commonly known haemorrhagic disorder causing bleeding due to defects in the coagulation factors. This leads to delay in the coagulation process post injury. Haemophilia is usually an X linked recessive inherited disease, but in some rare conditions, it has been found to be acquired.[3][4]

History of Haemophilia[edit | edit source]

The observation of bleeding disorders in males happened early in the 2nd century. The Talmud stated that if 2 brothers had bled to death after circumcision then the next brother shouldn’t be circumcised. Also in the 12th century the Arabic physician al-Zahrāwī, known as Albucasis, described the death of male family members due to excessive haemorrhage after an injury.[5]

The first medical description of haemophilia was made by the physician John Conrad Otto in the 19th century. He successfully linked this bleeding disorder to a sex linked inheritance; this was followed by another genetic description of haemophilia by Nasse in 1820. He stated that haemophilia is transmitted from carrier mothers to their male offspring. Finally, the term “haemophilia” appeared in 1928 in the University of Zurich by Hopff.[5]

Genetic Inheritance[edit | edit source]

Genetic.png

The term sex-linked refers to genes on the Sex chromosomes (usually the larger chromosome “X”)[6].

Genetic inheritance can either be dominant or recessive.

Females (XX) carry two X chromosomes. If a female carries a normal X-chromosome and a mutated X-chromosome. If the gene is recessive the female will be a carrier and will not suffer from the condition.[7] There is a 50% chance she will pass on the mutated x chromosome to her children.

Males (XY) only carry one X chromosome. If a male inherits a mutated X-chromosome he will be affected by the condition whether it is dominant or recessive.

Prevalence of Haemophilia[edit | edit source]

It was estimated that haemophilia was found in 1 in each 5000 male worldwide[8]. In 2019 a meta-analysis found that the number is larger than previously estimated. The researchers found that there is around 1,125,000 males that have bleeding disorders. The study also revealed that in every 100 000 males there are 17.1 with haemophilia A and 3.8 with haemophilia B [9][10]An updated statistic from a 2021 review found a prevalence of 12.8 per 100,000 males for haemophilia A[11].

Types of Haemophilia[edit | edit source]

Haemophilia is usually an inherited disease, but in rare cases, it can be acquired.

Inherited haemophilia[edit | edit source]

The type of haemophilia is determined according to the protein factor that defected[12]. There are three known types of haemophilia:[13][14]

Comparison between types of haemophilia[edit | edit source]

haemophilia A haemophilia B haemophilia C
Known as Classical / Standard haemophilia Christmas haemophilia Rosenthal’s disease
Protein factor affected Factor VIII Factor IX Factor XI
Genetic Inheritance X linked recessive X linked recessive Autosomal recessive
Gender Affected Mostly males Mostly Males Females & males equally
Severity Mild, Moderate and Severe Mild, Moderate and Severe Mild

Acquired haemophilia[edit | edit source]

Acquired haemophilia is rare and occurs as the result of an autoimmune disease that attacks the protein clotting factors (especially factor VIII) and subsequently leads to manifestations similar to haemophilia A.[13]

The Royal Disease[edit | edit source]

Queen Victoria was a carrier of haemophilia B. She passed the mutated gene to three of her children. Her two daughters became carriers and her son, Prince Leopold, had haemophilia. Queen Victoria’s children married many royals across Europe and Russia. Haemophilia B was spread among royals for many generations with royals being either a carrier or haemophilic.[2][15]

Manifestations of Haemophilia[edit | edit source]

Children with mild haemophilia do not show any manifestation except post-injury or dental extraction. Moderate and severe haemophiliacs may experience the following manifestations:[16]

  • Mouth bleeding post-dental extraction or cut.
  • Nose bleedings
  • Un-stoppable haemorrhage after a small injury or cut
  • Blood in urine and stool due to haemorrhage in the kidney / bladder/ intestines or stomach
  • Haematoma
  • Joint Bleeding
  • Muscle Bleeding

Diagnosis of Haemophilia[edit | edit source]

Screening Tests[edit | edit source]

Complete Blood Count[edit | edit source]

Complete Blood Count (CBC) may appear normal in persons with haemophilia. If the patient has already experienced a massive haemorrhage, the CBC count may appear low.[17]

Activated Partial Thromboplastin Time (APTT) Test[edit | edit source]

The APTT test measures the duration of blood clotting by measuring the clotting ability of factor VIII, IX, XI and XIII. In patients with haemophilia, the results will show a prolonged clotting time[17].

Prothrombin Time (PT) Test[edit | edit source]

The PT test measures the duration of blood clotting by measuring the clotting ability of factor I, II, V, VII. In patients with haemophilia, the results are normal.[17]

Clotting Factor Tests[edit | edit source]

Clotting factor tests are used to diagnosis haemophilia and its type and the degree of severity.  It measures the levels of factor VIII and IX.[17]

The Severity of Haemophilia[edit | edit source]

The severity of haemophilia is determined by the levels of clotting factor in the blood.[17]

Severity of haemophilia[edit | edit source]

Severity Levels of Factor VIII or IX in the blood
Normal 50% to 100%
Mild haemophilia Greater than 5% but less than 50%
Moderate haemophilia 1% to 5%
Severe haemophilia Less than 1%

Medical Management[edit | edit source]

Replacement Therapy[edit | edit source]

Concentrates of clotting factor VIII (for haemophilia A) or clotting factor IX (for haemophilia B) are slowly injected into a vein to replace the missed clotting factor. These concentrates can be extracted from human blood or synthesized (recombinant clotting factor).[18]

Preventative (prophylactic) therapy[edit | edit source]

Preventative therapy encompasses the usage of replacement therapy on a regular basis to prevent bleeding.[18]

Demand therapy

Demand therapy is a less intensive approach that encompasses the usage of replacement therapy only when the need arises.[18]

Complications of Replacement Therapy[18][edit | edit source]

  • May develop antibodies that attack the clotting factor
  • Susceptible to viral infections from human clotting factors
  • Damage to joints, muscles, or other parts of the body resulting from bleeding as a result of delays in treatment

Other Types of Treatment[edit | edit source]

Other types include Desmopressin (stimulates the production of the clotting factors), Antifibrinolytic Medicines and gene therapy)[18].

Recommended Treatment according to the severity of haemophilia[edit | edit source]

Severity of haemophilia Recommended Medical Management
Mild haemophilia Desmopressin

No replacement therapy

Moderate haemophilia Desmopressin

Replacement therapy during bleeding / prevent bleeding prior certain activities  or surgeries

Severe haemophilia Replacement therapy

Physical Therapy Management[edit | edit source]

The National haemophilia  Foundation formed a physical therapy working group that created the best physical therapy practice for bleeding disorders including haemophilia.[19]

The Medical and Scientific Advisory Council (MASAC) recommends physical therapy management in haemophilia because the most common manifestation is joint and muscle bleeding.[20]

Joints that have recurrent bleedings in haemophilia are known as “Target Joints”. The most common target joints are knee, elbow, ankle, hip and shoulders.[19]

The physiotherapy management of haemophilia is very similar to the management of Von Willebrand Disease.

Physiotherapy can also play a role in providing support and coaching, and in monitoring the musculoskeletal status of people with haemophilia.[21]

Physical Therapy Evaluation[edit | edit source]

According to the MASAC; the purpose of an evaluation is to detect the musculoskeletal and activities limitations caused by haemophilia.[22]

History and Interview[edit | edit source]

The patient and/or the caregiver is interviewed and the history is taken[22]:

  • Personal history.
  • Family history.
  • Bleeding history.
  • Medical and surgical history.
  • Pain history.
  • ADL concerns.
  • Occupational concerns.

Physical Examination[edit | edit source]

  • Palpation of joints at rest and during active range of motion to detect crepitus, synovitis, oedema or temperature.
  • Girth measurement to assess oedema/ muscle atrophy.
  • Atypical Joint End feel detection via the passive range of motion.
  • Manual Muscle Testing to assess muscular strength.
  • Muscle Flexibility test.
  • Sensation and proprioception.
  • Balance and fall assessment.
  • Posture and alignment assessment.
  • Assessment of functional activities.
  • Gait analysis.
  • Neuromotor assessment.
  • Musculoskeletal Ultrasound.

Physical Therapy Treatment[edit | edit source]

The recommended physical therapy program by MASAC for muscles and joints bleeding is different in each recovery phase. There are three recovery phases: Acute, Subacute and Chronic. The management for all muscles follow specific guidelines, except for iliopsoas muscle, and all physical therapy suggested protocols are performed post factor replacement medication as follows:[23]

Physical Therapy Guidelines in Different Recovery Phases of Haemophilia[edit | edit source]

Acute Phase Subacute Phase Chronic Precautions
Muscles Bleeding except for iliopsoas Main Problem:

Present pain at rest and with movement

Main Problem :

Limitations in ADL without increasing pain from baseline

Main Problem :

ADL limitation but without pain

  • Monitor for neurovascular compromise while Splinting
  • Caution with use of compression on the affected muscle.
  • Use of heat modalities including ultrasound  with precautions
  • Ultrasound for blood absorption can be used with precautions.
Physical Therapy Program:
  • Avoid compression in the presence of neuromuscular symptoms.
  • No active movement or weight bearing till bleeding stoppage.
  • Splinting.
  • RICE: Rest, Ice, Compression & Elevation
  • TENS
Physical Therapy Program:
  • Splinting and assistive device to limit activity
  • Toe touch weight bearing
  • Isometric contractions
  • Active range of motion
  • Positioning
  • AAROM without pain
  • TENS
Physical Therapy Program:
  • Full Weight Bearing without assistive devices
  • Positional stretching
  • Active Range of Motion exercises
  • unrestricted lifting
  • Re-evaluation.
Iliopsoas Muscle Bleeding Main Problem:

pain presented at rest and with movement

Main Problem :

ADL limitation without increase pain from baseline

Main Problem :

ADL limitation but without pain

Monitor for femoral nerve palsy
Physical Therapy Program :
  • Bedrest
  • Toe Touch Weight Bearing for household mobility
  • Rest
  • Opposite limb ROM Ankle pumps involved lower limb with pain avoidance
Physical Therapy Program:
  • Toes touch weight bearing without increase in pain
  • Isometric contractions
  • Active Range Of Motion exercises to involved Lower limb without increase in pain
  • Positioning with increasing hip extension Range Of Motion in supine and prone over pillows without increase in pain.
  • therapeutic exercises for non-involved limb
Physical Therapy Program:
  • Full Weight Bearing without  assistive devices
  • Positional stretches from prone position
  • Active range of motion exercises
  • Re-evaluation
Joint Bleeding Main Problem:

pain presented at rest and with movement

Main Problem :

ADL limitation without increase pain from baseline

Main Problem :

ADL limitation but without pain

  • Avoid aggressive exercise too early
  • Monitor for nerve compression
  • Use of heat modalities including ultrasound with precautions
  • No return to sports or activity until pain-free full ROM and strength
Physical Therapy Program :
  • RICE (ice for 10-20 minutes every 1-2 hours)
  • Splinting
  • Non Weight Bearing using  assistive device
Physical Therapy Program :
  • Continue RICE for pain and after exertion Splinting
  • Night resting splint for protection
  • Begin progressive weight bearing
  • Activity modification to avoid pain
  • Pain-free gentle active Range of motion
  • Pain-free progressive strengthening
Physical Therapy Program :
  • Dynamic splinting to increase ROM
  • Active range of motion Progressive
  • Strengthening as Open chain, closed chain and resistive band
  • Proprioceptive training
  • Gentle joint mobilizations
  • Modified functional activities
  • Orthotics
  • Reevaluations

There are also some modalities and physical therapy tools that have been researched across the years to help patients with haemophilia. EMG biofeedback may be helpful with muscle strenthening and relaxation [24]

Kinesio Tape[edit | edit source]

It was shown the Kinesio tape plays a role in haemophilia by supporting the muscles, allowing joint movement with support, decreasing pain and decreasing hematoma.[25]

Transcutaneous Electrical Neurostimulation[edit | edit source]

It was shown that Transcutaneous electrical neurostimulation (TENS) has an impact on reducing pain for patients with haemophilia. It is applied as a low intensity electrical impulse to stimulate peripheral nerves. That inhibits pain information transmission along nerves.[26]

Related update: another treatment modality available to some physiotherapists, laser therapy, is showing promise for improving the functional capacity of patients with haemophilic arthropathy.[27]

Manual Therapy[edit | edit source]

Manual therapy such as fascial therapy, passive mobilization and stretching; manual orthopaedic therapy and proprioception training are recommended for physical therapy management for cases with haemophilia,[28] but joint traction as a manual therapy technique.[29]

haemophilia is a congenital X-linked bleeding disorder in which blood does not properly clot. It is categorized as a disorder of haemostasis. haemostasis, the stopping of bleeding after a blood vessel is injured, normally is divided into two separate processes—primary and secondary haemostasis. In haemophilia, secondary haemostasis (which essentially results in the formation of a fibrin clot) is defected. Thus, deficient clotting is due to an abnormality of the functional plasma-clotting proteins, factors VIII and IX, that are involved in this process. [30]

Differential Diagnosis[edit | edit source]

It is important to ensure haemophilia is properly diagnosed. Below are other medical issues or impairments that may present similarly and if not diagnosed appropriately could lead to a variety of medical issues.

  • Nerve impingement: A person with haemophilia may experience bleeding into the iliacus muscle or the psoas. Bleeding in these areas can apply pressure to the femoral nerve branch that supplies the skin of the anterior thigh and a person may have a loss of sensation.
  • Appendicitis: A person with haemophilia may have symptoms that mimic appendicitis when they have muscle bleeding on the right side in their lower abdomen.[30]
  • Disseminated Intravascular Coagulation (DIC)[31]
  • Von Willebrand Disease (VWD)[32]
  • Thrombocytopenia[33]

Case Reports/ Case Studies[edit | edit source]

  1. Girardi D da M, Silva DRA, Villaça PR, Souza CE, Fonseca LG, Bastos DA, Hoffa PMG. Acquired haemophilia A in a patient with advanced prostate cancer. Journal of Autopsy & Case Reports. 2015;5(2):55-59. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4584669/
  2. Iioka F, Shimomura D, Nakamura F, Ohno H, Yada K, Nogami K, Shima M. Long-term treatment course of a patient with mild haemophilia A who developed a high titre factor VIII inhibitor. Journal of Haemophilia. 2014;20(6):e402-e404.
    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232888/
  3. Janbain M, Leissinger CA, Kruse-Jarres R. Acquired haemophilia A: emerging treatment options. Journal of blood medicine. 2015;6:143-150.
    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431493/

Resources[edit | edit source]

References[edit | edit source]

  1. Escobar M, Nguyen T. Hemophilia. In: Reference Module in Biomedical Research [Internet]. 3rd ed. Elsevier Inc.; 2014. p. 1–8.
  2. 2.0 2.1 O’Neill C. Royal blood: Queen Victoria and the legacy of hemophilia in European royalty [Internet]. Hekton International. 2020 [cited 2020 Jul 1].
  3. Nesterova AP, Klimov EA, Zharkova M, Sozin S, Sobolev V, Ivanikova N V., et al. Diseases of the Blood. In: Disease Pathways [Internet]. Elsevier Inc; 2019. p. 112–9.
  4. Marchesini E, Morfini M, Valentino L. Recent advances in the treatment of hemophilia: a review. Biologics: Targets & Therapy. 2021;15:221.
  5. 5.0 5.1 Franchini M, Mannucci PM. The History of Hemophilia. Semin Thromb Hemost [Internet]. 2014;40(5):571–6.
  6. Easter C. ​Sex Linked [Internet]. National Human Genome Institude. 2020 [cited 2020 Jul 3].
  7. Medline Plus. Sex-linked recessive [Internet]. National Libraray of Medicine. 2020 [cited 2020 Jul 3].
  8. National Center on Birth Defects and Developmental Disabilities. What is Hemophilia?. Centers for Disease Control and Prevention. 2020 [cited 2020 Jul 2].
  9. Inserro A. Prevalence of Hemophilia Worldwide Is Triple That of Previous Estimates, New Study Says American Journal of Managed Care. 2019 [cited 2020 Jul 2].
  10. Iorio A, Stonebraker JS, Chambost H, Makris M, Coffin D, Herr C, et al. Establishing the Prevalence and Prevalence at Birth of Hemophilia in Males. Ann Intern Med [Internet]. 2019 Sep 10;171(8):540–6.
  11. Berntorp E, Fischer K, Hart DP, Mancuso ME, Stephensen D, Shapiro AD, Blanchette V. Haemophilia. Nature Reviews Disease Primers. 2021 Jun 24;7(1):1-9.
  12. Hemophilia of Georgia. Types of Hemophilia. In: The Hemophilia, von Willebrand Disease & Platelet Disorders Handbook [Internet]. Hemophilia of Georgia; 2020 [cited 2020 Jul 3]
  13. 13.0 13.1 Shapiro AD. Hemophilia B [Internet]. National Organization of Rare Diseases. 2020.
  14. Bolton-Maggs P. Hemophilia C [Internet]. Medscape. 2019 [cited 2020 Jul 3].
  15. Mathew G. Know All About Hemophilia – The Royal Disease [Internet]. Medlife Wellness. 2020 [cited 2020 Jul 3]. Available from:
  16. Symptoms of Hemophilia [Internet]. Hemophilia News Today. 2020 [cited 2020 Jul 5].
  17. 17.0 17.1 17.2 17.3 17.4 Centers for Disease Control and Prevention. Diagnosis of Hemophilia [Internet]. National Center on Birth Defects and Developmental Disabilities. 2019 [cited 2020 Jul 5]. Available from:
  18. 18.0 18.1 18.2 18.3 18.4 National Heart, Lung, and Blood Institute NI of H. How Is Hemophilia Treated? [Internet]. Centers for Cancer Care and Blood Disorders. 2020 [cited 2020 Jul 5].
  19. 19.0 19.1 Lowes LP, Alfano L, Orlin MN. Muscloskeltal System: Considerations and Interventions for Specific Pediatric Pathology. In: Effgen SK, editor. Meeting the Physical Therapy Needs of Children. 2nd ed. Philadelphia: F. A. Davis Company; 2013. p. 226–7.
  20. Medical and Scientific Advisory Counsil. MASAC Document #238: Recommendations Regarding Physical Therapy Guidelines in Patients with Bleeding Disorders. Natl Hemoph Found. 2015;238.
  21. Lobet S, Timmer M, Königs C, Stephensen D, McLaughlin P, Duport G, Hermans C, Mancuso ME. The Role of Physiotherapy in the New Treatment Landscape for Haemophilia. Journal of Clinical Medicine. 2021 Jun 26;10(13):2822.
  22. 22.0 22.1 Medical and Scientific Advisory Council. Physical Therapy Evaluation Recommendations. Natl Hemoph Found. 2018;
  23. National Hemophilia Foundation. Physical Therapy Practice Guidelines for Persons with Bleeding Disorders: Muscle Bleed. 2018;
  24. Culbert T, Banez G. Pediatric Applications. In: Schwartz M, Andrasik F, editors. Biofeedback, Fourth Edition: A Practitioner’s Guide. 4th ed. The Guilford Press; 2017.
  25. Zolotnitsky M. The Benefits of Kinesio Taping: Ask The HemoDoc [Internet]. BioMatrix. 2019 [cited 2020 Jul 5].
  26. Riley RR, Witkop M, Hellman E, Akins S. Assessment and management of pain in Hemophilia Patients. Hemophilia. 2011;17:839–45.
  27. Elshennawy S, Zahreldin AA, Mortada H, Hozien M, Youssef AS, Galal A, Shahien M, Elfeky A, Elaraby A, Hamed M. The efficacy of Physical therapy modalities in patients with haemophilia: a systematic review of randomized controlled trials with meta-analysis. Archives of Physical Medicine and Rehabilitation. 2022 Jul 19.
  28. Donoso-Úbeda E, Meroño-Gallut J, López-Pina JA, Cuesta-Barriuso R. Effect of manual therapy in patients with hemophilia and ankle arthropathy: a randomized clinical trial. Clin Rehabil. 2020;34(1):111–9
  29. Cuesta-Barriuso R, Trelles-Martínez RO. Manual therapy in the treatment of patients with hemophilia B and inhibitor. BMC Musculoskelet Disord. 2018;19(1):1–5.
  30. 30.0 30.1 Goodman CC, Snyder TEK. Differential Diagnosis for Physical Therapists: Screening for Referral. 5th ed. St. Louis: Elsevier Inc, 2013.
  31. MedlinePlus. Disseminated intravascular coagulation (DIC). https://www.nlm.nih.gov/medlineplus/ency/article/000573.htm (accessed 8 April 2016).
  32. Centers for Disease Control and Prevention. Facts About von Willebrand Disease. http://www.cdc.gov/ncbddd/vwd/facts.html (accessed 8 April 2016).
  33. National Heart, Lung, and Blood Institute. What Is Thrombocytopenia?. http://www.nhlbi.nih.gov/health/health-topics/topics/thcp/ (accessed 8 April 2016).